Zoetis Inc. (ZOE.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ZOE.DE in your mock portfolio yet.
With EPS of 5.59 and a PE ratio of 11.90, Zoetis appears solidly profitable and currently valued at a discount to what is typical for a high‑quality animal health franchise. The earnings power implied by EPS, combined with a relatively low multiple, suggests the market may be underpricing the durability of its cash flows, assuming no major structural issues in the business. Overall, the profitability profile leans positive even if the market is cautious.
The stock trades at €66.54, well below its 200‑day moving average of €90.20, indicating a sustained downtrend despite a modest 0.6% gain over the last month. An RSI of 45.07 is neutral-to-weak, showing neither oversold capitulation nor strong buying momentum. Overall, price action and trend structure remain negative, with only tentative signs of stabilization.
Alternative data for Zoetis is mixed but slightly constructive: job openings at 195 and up 7.1% month over month point to continued investment and growth initiatives. Web traffic at ~291k monthly visitors and slowly growing social channels indicate a stable, not explosive, digital footprint. The data suggests a steady, healthy business rather than one experiencing either strong acceleration or deterioration.
Zoetis shows fundamentally solid profitability at a relatively low earnings multiple, but its share price remains in a clear downtrend below the 200‑day moving average. Alternative data points to a stable and modestly expanding business, yet without strong momentum signals. Overall, the setup appears neutral: fundamentally supportive with a potentially attractive valuation, but technically weak and awaiting clearer signs of a sustained recovery in sentiment and price.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started